Chenghui Shuangda
About the Exhibition
Pharmaconex is the largest and most influential pharmaceutical industry event in Egypt and North Africa, focusing on pharmaceutical raw materials, equipment technology, and the integration of the entire industrial chain. It serves as a core platform for expanding into the Egyptian and African markets.
The exhibition is organised by Informa, a renowned UK-based exhibition company with extensive experience and strong capabilities. Since its inception, it has consistently provided high-quality resources and professional services, meeting the needs of the Middle East and North African markets while offering pharmaceutical, raw material, and pharmaceutical packaging companies opportunities to expand their business networks in Egypt and neighbouring countries, and establishing an integrated business platform for solutions.
The exhibition area is expected to span 12,000 to 25,000 square metres, attracting 350 to 600 global companies and 8,500 to 15,000 professional visitors.
Exhibition scope
Pharmaceutical raw materials and intermediates: vitamins, hormones, antipyretic and analgesic drugs, cardiovascular drugs, anti-infective drugs, etc.
Pharmaceutical equipment and technology: dryers, water treatment equipment, sterilisation equipment, tablet presses, packaging machinery.
Pharmaceutical packaging materials: PVC/PVDC composite sheets, PS sheets, packaging anti-counterfeiting technology, label application equipment.
Laboratory equipment and reagents: biochemical analysis instruments, consumables, cleanroom technology, etc.
Nutritional supplements sector: plant extracts, functional food ingredients, vitamin supplements, etc.
Previous editions
At previous Pharmaconex International Pharmaceutical Exhibitions, Chenghui Pharmaceutical attracted numerous prospective customers to stop and discuss business opportunities with its innovative booth design and cutting-edge product portfolio.
About Us
Shandong Chenghui Pharmaceutical Group Co., Ltd. was established in June 2002, with its headquarters located at No. 2350 Kaituo Road, High-Tech Zone, Jinan City, and a registered capital of 130 million yuan. The company specialises in the research, development, production, and sales of pharmaceutical raw materials, intermediates, and fine chemical products. It operates one research and development centre (Shandong Chengchuang Lanhai Pharmaceutical Technology Co., Ltd.), one raw material pharmaceutical factory (Shandong Chenghui Shuangda Pharmaceutical Co., Ltd.), and two modern pharmaceutical intermediate production bases. The company currently employs over 1,000 staff members, including over 300 R&D personnel.
The company has a complete pharmaceutical industry chain layout, with six GMP-compliant API production workshops, an annual production capacity of over 1,000 tonnes, and over 240 sets of reaction equipment with a total reaction volume of 550 cubic metres, meeting international standards such as GMP and FDA. Its main products cover 13 approved APIs across categories such as local anaesthetics, antivirals, and cardiovascular drugs (e.g., fumaric acid vonorelin, lidocaine hydrochloride, and bupivacaine hydrochloride), with over 20 ongoing registration projects. The company also provides CDMO services across pharmaceutical intermediates, veterinary drugs, and nutritional health products.
In the dialogue between the millennia-old civilisation along the Nile and modern pharmaceuticals, Chenghui Pharmaceutical sincerely invites you to attend the Pharmaconex Exhibition (Cairo International Exhibition Centre, Egypt) from 1 to 3 September 2025, to jointly open a new chapter in China-Africa pharmaceutical industry cooperation!
E
